Platelet Glycoprotein IIb/IIIa Receptor Antagonists in Cardiovascular Disease
Open Access
- 21 April 1999
- journal article
- review article
- Published by American Medical Association (AMA) in JAMA
- Vol. 281 (15) , 1407-1414
- https://doi.org/10.1001/jama.281.15.1407
Abstract
Atherosclerotic heart disease is the most common cause of death in developed countries.1 Thrombosis with platelet deposition and fibrin formation begins immediately (within 1-24 hours) after spontaneous or mechanical injury and is usually mural and subocclusive.2 Plaque disruption activates the coagulation cascade leading to thrombin generation. Exposure of deeper components of atherosclerotic plaques (collagen, tissue factor) and thrombin generated by arterial injury are powerful platelet activators (Figure 1). Angiographic,4,5 angioscopic,6 pathologic,7 and biochemical8 evidence support the role of thrombus in the pathogenesis of acute myocardial infarction (MI), unstable angina, and percutaneous coronary intervention.9Keywords
This publication has 2 references indexed in Scilit:
- Faculty Opinions recommendation of Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction.Published by H1 Connect ,2018
- Angiographic occurrence and clinical correlates of intraluminal coronary artery thrombus: Role of unstable anginaJournal of the American College of Cardiology, 1985